• 1.

    Amaral JK, Taylor PC, Teixeira MM, Morrison TET, Schoen RT, 2019. The clinical features, pathogenesis and methotrexate therapy of chronic chikungunya arthritis. Viruses 11: 289.

    • Search Google Scholar
    • Export Citation
  • 2.

    Suhrbier A, 2019. Rheumatic manifestations of chikungunya: emerging concepts and interventions. Nat Rev Rheumatol 15: 597611.

  • 3.

    Robinson MC, 1955. An epidemic of virus disease in southern province, Tanganyika territory, in 1952–1953. I. Clinical features. Trans R Soc Trop Med Hyg 49: 2832.

    • Search Google Scholar
    • Export Citation
  • 4.

    Monge P 2019. Pan-American league of associations for rheumatology-central American, Caribbean and Andean rheumatology association consensus-conference endorsements and recommendations on the diagnosis and treatment of chikungunya-related inflammatory arthropathies in Latin America. J Clin Rheumatol 25: 101107.

    • Search Google Scholar
    • Export Citation
  • 5.

    Arroyo-Ávila M, Cabán A, García-Rivera EJ, Irizarry-Pérez M, Torres H, Gorbea H, Vilá LM, 2017. Clinical manifestations associated with peripheral joint involvement in patients with acute chikungunya virus infection. Am J Trop Med Hyg 96: 916921.

    • Search Google Scholar
    • Export Citation
  • 6.

    Edington F, Varjão D, Melo P, 2018. Incidence of articular pain and arthritis after chikungunya fever in the Americas: a systematic review of the literature and meta-analysis. Joint Bone Spine 85: 669678.

    • Search Google Scholar
    • Export Citation
  • 7.

    Rodríguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzón S, Sebastian Hurtado-Zapata J, 2016. Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 68: 18491858.

    • Search Google Scholar
    • Export Citation
  • 8.

    Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K, 2013. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J: 89: 440447.

    • Search Google Scholar
    • Export Citation
  • 9.

    Delgado-Enciso I 2018. Smoking and female sex as key risk factors associated with severe arthralgia in acute and chronic phases of Chikungunya virus infection. Exp Ther Med 15: 26342642.

    • Search Google Scholar
    • Export Citation
  • 10.

    Bouquillard E, Fianu A, Bangil M, Charlette N, Ribéra A, Michault A, Favier F, Simon F, Flipo RM, 2018. Rheumatic manifestations associated with Chikungunya virus infection: a study of 307 patients with 32-month follow-up (RHUMATOCHIK study). Joint Bone Spine 85: 207210.

    • Search Google Scholar
    • Export Citation
  • 11.

    Rahim AA, Thekkekara RJ, Bina T, Paul BJ, 2016. Disability with persistent pain following an epidemic of chikungunya in rural south India. J Rheumatol 43: 440444.

    • Search Google Scholar
    • Export Citation
  • 12.

    Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, Sudeep AB, Muruganandam N, Chaitanya IK, Guruprasad DR, 2010. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104: 392399.

    • Search Google Scholar
    • Export Citation
  • 13.

    Bertolotti A Chronic Chikungunya Working Group of University Medical Center of Martinique, 2020. Prevalence of chronic chikungunya and associated risks factors in the French West Indies (La Martinique): a prospective cohort study. PLoS Negl Trop Dis 14: e0007327.

    • Search Google Scholar
    • Export Citation
  • 14.

    Chang AY 2018. Frequency of chronic joint pain following chikungunya virus infection: a Colombian cohort study. Arthritis Rheumatol 70: 578584.

    • Search Google Scholar
    • Export Citation
  • 15.

    Huits R 2018. Chikungunya virus infection in Aruba: diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia. PLoS One 13: e0196630.

    • Search Google Scholar
    • Export Citation
  • 16.

    Murillo-Zamora E, Mendoza-Cano O, Trujillo-Hernández B, Guzmán-Esquivel J, Higareda-Almaraz E, Higareda-Almaraz MA, Sánchez-Piña RA, Lugo-Radillo A, 2018. Persistent arthralgia and related risks factors: a cohort study at 12 months from laboratory-confirmed chikungunya infection. Arch Med Res 49: 6573.

    • Search Google Scholar
    • Export Citation
  • 17.

    Arroyo-Ávila M, Vilá LM, 2015. Rheumatic manifestations in patients with chikungunya infection. P R Health Sci J 34: 7177.

  • 18.

    Amaral JK, Bilsborrow JB, Schoen RT, 2019. Brief report: the disability of chronic chikungunya arthritis. Clin Rheumatol 38: 20112014.

  • 19.

    Hayd RLN, Moreno MR, Naveca F, Amdur R, Suchowiecki K, Watson H, Firestein GS, Simon G, Chang AY, 2020. Persistent chikungunya arthritis in Roraima, Brazil. Clin Rheumatol 39: 27812787.

    • Search Google Scholar
    • Export Citation
  • 20.

    Ravindran V, Alias G, 2017. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol 36: 13351340.

    • Search Google Scholar
    • Export Citation
  • 21.

    Zaid A, Gérardin P, Taylor A, Mostafavi H, Malvy D, Mahalingam S, 2018. Chikungunya arthritis: implications of acute and chronic inflammation mechanisms on disease management. Arthritis Rheumatol 70: 484495.

    • Search Google Scholar
    • Export Citation
  • 22.

    Aletaha D, Smolen J, 2005. The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23: S100S108.

    • Search Google Scholar
    • Export Citation
  • 23.

    Bruce B, Fries JF, 2003. The stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation. J Rheumatol 30: 167178.

    • Search Google Scholar
    • Export Citation
  • 24.

    Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A, 2013. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 7: e2137.

    • Search Google Scholar
    • Export Citation
  • 25.

    Donath MY, Shoelson SE, 2011. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98107.

  • 26.

    Teng TS, Kam YW, Lee B, Hapuarachchi HC, Wimal A, Ng LC, Ng LF, 2015. A systematic meta-analysis of immune signatures in patients with acute chikungunya virus infection. J Infect Dis 211: 19251935.

    • Search Google Scholar
    • Export Citation
  • 27.

    Chaaitanya IK, Muruganandam N, Sundaram SG, Kawalekar O, Sugunan AP, Manimunda SP, Ghosal SR, Muthumani K, Vijayachari P, 2011. Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol 24: 265271.

    • Search Google Scholar
    • Export Citation
  • 28.

    Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V, 2009. Post-epidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 3: e389.

    • Search Google Scholar
    • Export Citation
  • 29.

    Heath CJ, Lowther J, Noël TP, Mark-George I, Boothroyd DB, Mitchell G, MacPherson C, Desiree LaBeaud A, 2018. The identification of risk factors for chronic chikungunya arthralgia in Grenada, West Indies: a cross-sectional cohort study. Open Forum Infect Dis 5: ofx234.

    • Search Google Scholar
    • Export Citation
  • 30.

    Amaral JK, Bingham CO 3rd, Schoen RT, 2020. Successful methotrexate treatment of chronic chikungunya arthritis. J Clin Rheumatol 26: 119124.

  • 31.

    Chang AY 2018. Chikungunya arthritis mechanisms in the Americas: a cross-sectional analysis of chikungunya arthritis patients twenty-two months after infection demonstrating no detectable viral persistence in synovial fluid. Arthritis Rheumatol 70: 585593.

    • Search Google Scholar
    • Export Citation
  • 32.

    Wolfe F, 2000. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 43: 27512761.

  • 33.

    Carmona L, Ballina J, Gabriel R, Laffon A; EPISER Study Group, 2001. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60: 10401045.

    • Search Google Scholar
    • Export Citation
  • 34.

    Georgiev T, 2019. Clinical characteristics and disability in patients with knee osteoarthritis: real world experience from Bulgaria. Reumatologia 57: 7884.

    • Search Google Scholar
    • Export Citation
  • 35.

    Wolfe F, Walitt BT, Katz RS, Häuser W, 2014. Social security work disability and its predictors in patients with fibromyalgia. Arthritis Care Res (Hoboken) 66: 13541363.

    • Search Google Scholar
    • Export Citation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis

View More View Less
  • 1 Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico;
  • 2 Department of Microbiology and Medical Zoology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico;
  • 3 Hispanic Alliance for Clinical and Translational Research, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

ABSTRACT

Most studies on chronic chikungunya virus (CHIKV) arthritis include patients treated with disease-modifying antirheumatic drugs (DMARDs), likely altering the expression of clinical manifestations and outcome. Therefore, we sought to evaluate the clinical features and correlates in DMARD-naive patients with chronic CHIKV arthritis. We conducted a case–control study in adult patients with serologically confirmed CHIKV infection in Puerto Rico. Demographic features, clinical manifestations, comorbidities, disease activity (per Clinical Disease Activity Index [CDAI]), functional status (per Health Assessment Questionnaire Disability Index [HAQ-DI]), and pharmacologic treatment were ascertained. Patients with and without chronic CHIKV arthritis were compared. Furthermore, a sub-analysis was performed among patients with chronic CHIKV who presented with mild disease activity versus moderate-to-high disease activity at study visit. In total, 61 patients were studied; 33 patients had chronic arthritis and 28 had resolved arthritis. Patients with chronic arthritis had significantly more diabetes mellitus, chronic back pain, and fever, tiredness, and myalgias on the acute phase. The mean (SD) HAQ score was 0.95 (0.56), and 57.6% had moderate-to-high disease activity. Patients with moderate-to-high disease activity had higher scores in overall HAQ-DI and HAQ-DI categories (dressing and grooming, arising, hygiene, reaching, and activities) than in those with mild activity. In conclusion, in this group of DMARD-naive patients with chronic CHIKV arthritis, nearly 58% had moderate-to-high disease activity and had substantial functional disability. Diabetes mellitus, chronic back pain, and some manifestations on acute infection were associated with chronic CHIKV arthritis.

Author Notes

Address correspondence to Luis M. Vilá, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, P.O. Box 365067, San Juan PR 00936-5067, Puerto Rico. E-mail: luis.vila2@upr.edu

Financial support: This work was supported by the National Institute of General Medical Sciences (NIGMS) grant number U54GM133807 for the Hispanic Alliance for Clinical and Translational Research and the National Institute of Minority Health and Health Disparities grant number G12MD007600 for the Research Centers for Minority Institutions (RCMI) Program.

Authors’ addresses: Nicolle Medina-Cintrón, Yaritza Berríos-López, and Luis M. Vilá, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, E-mails: nicolle.medina@upr.edu, yaritza.berrios@upr.edu, and luis.vila2@upr.edu. Idali Martínez, Department of Microbiology and Medical Zoology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, E-mail: idali.martinez@upr.edu. Naydi Pérez-Ríos, Hispanic Alliance for Clinical and Translational Research, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, E-mail: naydi.perez@upr.edu.

Save